All pharmaceutical manufacturing articles
-
BusinessNovo Holdings to buy contract manufacturer Catalent for $16.5 billion
Parent firm will then sell on three manufacturing sites to Novo Nordisk to boost capacity for diabetes and weight loss drugs
-
WebinarUnlocking the future of the chemical industry: the transformative potential of biocatalysis
Join us to learn how scientists are addressing the use of biocatalysis or chemoenzymatic catalysis within industry
-
BusinessPharmaceuticals roundup 2023
Regulatory and pricing reforms have topped industry agendas in 2023, while weight loss drugs surged and Covid-19 therapies waned
-
OpinionCompounding problems
Regulating the line between a vital service and grey-market profiteering is a mess
-
BusinessWeight-loss drug shortages prompt copycats and counterfeits
Novo Nordisk and Eli Lilly have struggled to meet huge demand for new hormone mimic obesity treatments
-
BusinessTornado at Pfizer plant accentuates US drug shortage issues
Perennial problem will not be addressed without major reforms to drug market
-
OpinionResistant to change
Curbing industrial practices that drive antimicrobial resistance needs tighter regulation and enforcement
-
BusinessHow can we maintain the effectiveness of existing antimicrobials?
Reducing environmental pollution and tackling quality issues to stave off resistance
-
WebinarData-driven materials innovation: where machine learning meets physics
Speed up materials innovation, save time & cost by leveraging a combination of physics-based simulations and chemistry-informed machine learning
-
WebinarUsing crystallographic structures & data-driven solutions to advance drug design
Learn how structural data can be used to empower molecular discovery at each stage of the drug design pipeline
-
OpinionBringing drug manufacturing back home
Pharmaceutical supply chains are international, complex and opaque. Is there a better way?
-
WebinarCutting-edge cosmetics: innovating for sustainability with machine learning & molecular simulations
Learn how to save cost, reduce time and drive innovation in developing sustainable cosmetic formulations
-
BusinessDeadly explosion and fire at US pharmaceutical plant
One worker killed and four hospitalised at Seqens in Newburyport
-
WebinarAnalytical impurity standards – minimise project risk & avoid common pitfalls
Learn how to save time and money by understanding what’s at stake when working with analytical impurity standards.
-
WebinarEmpower your drug design & synthesis with vibrational circular dichroism (VCD)
Discover the advantage and benefits of VCD compared to other analytical techniques and learn how to develop a more efficient workflow
-
WebinarBroadband benchtop NMR spectroscopy: it’s more than just protons
Join us for an introduction to broadband NMR spectroscopy – and see how the Oxford Instruments X-Pulse enables applications using a wide range of nuclei
-
WebinarResolving absolute stereochemistry in early drug discovery with VCD
From sample preparation to use of quantum chemical software tools, learn how vibrational circular dichroism (VCD) streamlines chiral analysis in the R&D analytical support lab
-
WebinarDriving the development of bio-based polymers with molecular simulation
Large-scale molecular simulations minimise costs and reduce the time it takes to develop bio-based polymer materials
-
WebinarEfficient modelling of polymers for industrial applications using molecular dynamics
Learn how simulations can elevate polymer modelling and enhance your workflow
-
WebinarUnlock the potential of definitive screening designs to drive your projects forward
In this webinar we help demystify DSDs and reveal how their complexity can be harnessed for manufacturing processes